Navellier & Associates’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-13,429
| Closed | -$1.53M | – | 337 |
|
|
2025
Q4 | $1.53M | Sell |
13,429
-5,185
| -28% | -$588K | 0.17% | 119 |
|
|
2025
Q3 | $2.04M | Buy |
+18,614
| New | +$1.95M | 0.21% | 111 |
|
|
2024
Q4 | – | Sell |
-24,432
| Closed | -$2.73M | – | 344 |
|
|
2024
Q3 | $2.73M | Sell |
24,432
-6,872
| -22% | -$753K | 0.37% | 73 |
|
|
2024
Q2 | $3.27M | Buy |
31,304
+3,738
| +14% | +$393K | 0.38% | 66 |
|
|
2024
Q1 | $3.02M | Buy |
+27,566
| New | +$2.91M | 0.37% | 73 |
|
|
2023
Q3 | – | Sell |
-33,254
| Closed | -$3.6M | – | 322 |
|
|
2023
Q2 | $3.6M | Buy |
+33,254
| New | +$3.56M | 0.7% | 54 |
|
|
2022
Q3 | – | Sell |
-52,000
| Closed | -$5.36M | – | 277 |
|
|
2022
Q2 | $5.36M | Buy |
+52,000
| New | +$5.6M | 1.15% | 15 |
|
|
2021
Q4 | – | Sell |
-60,880
| Closed | -$7.25M | – | 330 |
|
|
2021
Q3 | $7.25M | Sell |
60,880
-5,995
| -9% | -$734K | 1.09% | 23 |
|
|
2021
Q2 | $7.83M | Buy |
+66,875
| New | +$7.63M | 1.18% | 19 |
|
|
2021
Q1 | – | Sell |
-54,694
| Closed | -$5.89M | – | 297 |
|
|
2020
Q4 | $5.89M | Buy |
+54,694
| New | +$5.56M | 1.07% | 27 |
|
|
2020
Q1 | – | Sell |
-148,954
| Closed | -$12.5M | – | 251 |
|
|
2019
Q4 | $12.5M | Buy |
+148,954
| New | +$11.8M | 2.02% | 7 |
|
|
2018
Q4 | – | Sell |
-322,345
| Closed | -$27.4M | – | 254 |
|
|
2018
Q3 | $27.4M | Buy |
322,345
+7,353
| +2% | +$587K | 3.54% | 1 |
|
|
2018
Q2 | $23.4M | Buy |
+314,992
| New | +$22.8M | 3.25% | 2 |
|
|
2017
Q3 | – | Sell |
-270,306
| Closed | -$18.1M | – | 260 |
|
|
2017
Q2 | $18.1M | Buy |
270,306
+79,382
| +42% | +$5.1M | 2.7% | 3 |
|
|
2017
Q1 | $11.9M | Buy |
+190,924
| New | +$11.7M | 1.74% | 7 |
|
|
2016
Q4 | – | Sell |
-70,626
| Closed | -$4.3M | – | 291 |
|
|
2016
Q3 | $4.3M | Buy |
+70,626
| New | +$4.29M | 0.61% | 59 |
|
|
2015
Q3 | – | Sell |
-41,211
| Closed | -$2.84M | – | 341 |
|
|
2015
Q2 | $2.84M | Buy |
41,211
+8,834
| +27% | +$598K | 0.25% | 52 |
|
|
2015
Q1 | $2.17M | Buy |
+32,377
| New | +$2.06M | 0.2% | 58 |
|
|
2014
Q4 | – | Sell |
-26,616
| Closed | -$1.49M | – | 339 |
|
|
2014
Q3 | $1.49M | Buy |
+26,616
| New | +$1.46M | 0.07% | 70 |
|
|
2014
Q2 | – | Sell |
-5,877
| Closed | -$299K | – | 332 |
|
|
2014
Q1 | $299K | Buy |
+5,877
| New | +$299K | 0.01% | 256 |
|
|
2013
Q4 | – | Sell |
-1,363,901
| Closed | -$59.1M | – | 319 |
|
|
2013
Q3 | $59.1M | Buy |
1,363,901
+1,272,751
| +1,396% | +$53.7M | 1.74% | 17 |
|
|
2013
Q2 | $3.62M | Buy |
+91,150
| New | +$3.59M | 0.17% | 55 |
|
Other funds holding FXH
RW
PFA
Navellier & Associates's FXH Position: Q1 2026 in Review
Navellier & Associates sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q1 2026, closing a stake of 13,429 shares — an estimated $1.53M sold.
Navellier & Associates first reported a position in FXH in Q2 2013 and held it in 22 quarters. The position peaked at $59.1M in Q3 2013. 238 funds tracked by Wall St. Rank hold FXH as of Q1 2026.
- Navellier & Associates reported no remaining First Trust Health Care AlphaDEX Fund position as of Q1 2026 after selling out during the quarter.
- Navellier & Associates sold 13,429 First Trust Health Care AlphaDEX Fund shares in Q1 2026, an estimated $1.53M.
- Navellier & Associates first reported a position in First Trust Health Care AlphaDEX Fund in Q2 2013 and held it in 22 quarters.
- Navellier & Associates's First Trust Health Care AlphaDEX Fund position peaked at $59.1M in Q3 2013.
- 238 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q1 2026.
Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.